Advances in Bioengineering for Treatment of Metabolic Disorders
American Journal of Biomedical Engineering · 30.04.2022 · 3 (2) · 11-16
DOI: 10.71465/ajbe448 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biomedical Engineering, online erschienen am 30.04.2022. Verfasst von Dr. Emily Harris und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolic disorders, including diabetes, obesity, and dyslipidemia, represent a significant global health challenge. Recent advancements in bioengineering have opened new avenues for the treatment and management of these disorders, offering innovative solutions that go beyond conventional pharmaceutical approaches. This article reviews the role of bioengineering in the development of novel therapeutic strategies for metabolic disorders, focusing on areas such as gene therapy, tissue engineering, biosensors, and personalized medicine. It also highlights the potential of bioengineering technologies in addressing the root causes of metabolic diseases, promoting long-term health, and improving quality of life.
Zitieren
APA
Harris, D. E., & Smith, D. O. (2022). Advances in Bioengineering for Treatment of Metabolic Disorders. American Journal of Biomedical Engineering, 3(2), 11-16. https://doi.org/10.71465/ajbe448
Vancouver
Harris DE, Smith DO. Advances in Bioengineering for Treatment of Metabolic Disorders. American Journal of Biomedical Engineering. 2022;3(2):11-16. doi:10.71465/ajbe448
BibTeX
@article{Harris2022,
author = {Harris, Dr. Emily and Smith, Dr. Oliver},
title = {Advances in Bioengineering for Treatment of Metabolic Disorders},
journal = {American Journal of Biomedical Engineering},
year = {2022},
volume = {3},
number = {2},
pages = {11--16},
doi = {10.71465/ajbe448}
}
EUVIMED